Breast Biopsy is removal of cells or tissues from doubtful areas of breast. These cells or tissues are studied under a microscope to verify the presence of cancer. When a hollow needle is used to remove tissue samples from breast, it is known as core needle biopsy. It is the typical way to rule out or diagnose breast cancer. Core needle biopsy is done for the palpable mass or lump that can be felt, or suspicious area which is seen after mammogram or imaging test. Fine needle biopsy, also known as fine needle aspiration, removes the cells from suspicious lump in breast. The needle used for fine needle biopsy is thinner than the needle used for core needle biopsy. According to the American Cancer Society, 252,710 new cases of invasive breast cancer are projected to be diagnosed in women in the U.S. in 2017. About 63,410 new cases of carcinoma in situ (CIS) are anticipated to be diagnosed (CIS is non-invasive and is the earliest form of breast cancer). About 40,610 women are expected to die from breast cancer.

Different types of biopsies are core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, image-guided biopsy, incisional biopsy, excisional biopsy, shave biopsy, punch biopsy, endoscopic biopsy, and bone marrow aspiration & biopsy. Two major types of biopsies are needle biopsy and surgical biopsy. Needle biopsy involves usage of a needle to remove tissue sample. Surgical biopsy involves an incision to collect tissue sample. Core needle biopsy is done in imaging centers or hospitals. It is an image guided biopsy procedure. Advantages of core needle biopsy and fine needle biopsy are least chance of bruising or infection. If the lump is confirmed benign, then surgical biopsy is not required. However, there is a chance that the needle may miss the tumor cells, and hence misinterpret it as non-cancerous cell. Fine needle aspiration has false negative rate of 2% to 4%. Hence, fine needle aspiration can be followed by core needle biopsy or surgical biopsy.

Based on utility, the global needle aspiration biopsy market can be categorized into disposable and reusable. In terms of application, the market can be segmented into tumor, inflammation, infection, and others. Based on end-user, the global needle aspiration biopsy market can be classified into diagnostic & imaging centers, hospitals, academics & research centers, and others. Increase in prevalence and incidence of cancer globally and rise in awareness about diseases are the major factors fueling the growth of the global needle aspiration biopsy market. However, technological advancements in imaging such as computed tomography and magnetic resonance imaging are likely to restrain the global needle aspiration biopsy market. Emergence of fluid biopsy can also hamper the growth of the market.

The global needle aspiration biopsy market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to reflect a high CAGR due to significant patient population. Growing awareness among patients as well as health care professionals has led to increase in number of diagnosed cases of cancer in Asia, especially in China and India. North America is projected to dominate the global needle aspiration biopsy market due to factors such as rise in number of reported cancer cases, high per capita health expenditure, and significant investment in R&D for effective treatment alternatives.

Key players in the global needle aspiration biopsy market include Cook Medical, Boston Scientific Corporation, Hologic, Inc., Medax Srl Unipersonale, Cardinal Health, Inc., C. R. Bard, Inc., Becton, Dickinson and Company, Leica Biosystems Nussloch GmbH, Möller Medical GmbH, Hakko Co. Ltd., Argon Medical Devices, Inc., and COMPASS International Innovations, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Needle Aspiration Biopsy Market

Pre Book